SEC Comment Letter for ONCOLYTICS BIOTECH INC (ONCY) (CIK 0001129928) (ONCY) — Nov 1, 2016
ONCOLYTICS BIOTECH INC (ONCY) (CIK 0001129928)
Date: Nov. 1, 2016 · CIK: 0001129928 · Accession: 0000000000-16-099250
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-31062
Letter
Mail Stop 4546 November 1, 2016 Kirk Look Chief Financial Officer Oncolytics Biotech Inc. Suite 210, 1167 Kensington Crescent, N.W. Calgary, Alberta, T2N 1X7
Re: Oncolytics Biotech Inc. Form 20 -F for Fiscal Year Ended December 31, 2015 Filed March 24, 2016 File No. 000-31062
Dear Mr. Look :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Suzanne Hayes
Show Raw Text
Mail Stop 4546 November 1, 2016 Kirk Look Chief Financial Officer Oncolytics Biotech Inc. Suite 210, 1167 Kensington Crescent, N.W. Calgary, Alberta, T2N 1X7 Re: Oncolytics Biotech Inc. Form 20 -F for Fiscal Year Ended December 31, 2015 Filed March 24, 2016 File No. 000-31062 Dear Mr. Look : We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Suzanne Hayes Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Jason K. Brenkert, Esq. Dorsey & Whitney LLP